- Report
- August 2025
- 181 Pages
Global
From €3158EUR$3,545USD£2,731GBP
€3508EUR$3,939USD£3,035GBP
- Report
- August 2025
- 185 Pages
Global
From €3158EUR$3,545USD£2,731GBP
€3508EUR$3,939USD£3,035GBP
- Report
- May 2025
- 100 Pages
Global
From €5299EUR$5,950USD£4,584GBP
- Report
- April 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- March 2025
- 150 Pages
Global
From €3429EUR$3,850USD£2,966GBP
€4320EUR$4,850USD£3,736GBP
- Report
- April 2025
- 200 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- January 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,459GBP
- Report
- August 2025
- 281 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- August 2025
- 380 Pages
Global
From €5210EUR$5,850USD£4,507GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,079GBP
- Report
- June 2025
- 400 Pages
Global
From €4408EUR$4,949USD£3,813GBP
- Report
- February 2021
- 420 Pages
United States
From €1924EUR$2,160USD£1,664GBP
€2138EUR$2,400USD£1,849GBP
- Report
- August 2024
- 100 Pages
Global
From €5299EUR$5,950USD£4,584GBP
- Report
- March 2025
- 92 Pages
China
From €1603EUR$1,800USD£1,387GBP
- Report
- July 2025
- 200 Pages
Mexico
From €2218EUR$2,490USD£1,918GBP
- Report
- January 2024
- 200 Pages
Global
From €4453EUR$5,000USD£3,852GBP
- Report
- May 2024
- 128 Pages
Global
From €5788EUR$6,499USD£5,007GBP
- Report
- May 2024
- 140 Pages
Global
From €5788EUR$6,499USD£5,007GBP
- Report
- May 2024
- 128 Pages
Global
From €5788EUR$6,499USD£5,007GBP

Quetiapine is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a member of the atypical antipsychotic class of drugs, which are used to treat mental illnesses by altering the balance of certain chemicals in the brain. Quetiapine is one of the most commonly prescribed medications in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, including schizophrenia, bipolar disorder, and depression. Quetiapine is also used to treat anxiety, insomnia, and other sleep disorders.
Quetiapine is available in both immediate-release and extended-release formulations. The extended-release formulation is designed to provide a steady, consistent level of medication in the body over a longer period of time. Quetiapine is generally well-tolerated, with few side effects. Common side effects include drowsiness, dry mouth, and weight gain.
The quetiapine market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more